Nurix Therapeutics (NRIX) Net Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | -392.00 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 29,636.00 |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - | -89,145.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -89,145.00 |
| Feb 28, 2026 | -108,896.00 |
| Nov 30, 2025 | -13,538.00 |
| Aug 31, 2025 | -70,586.00 |
| May 31, 2025 | 26,974.00 |
| Feb 28, 2025 | -5,504.00 |
| Nov 30, 2024 | -16,398.00 |
| Aug 31, 2024 | -18,865.00 |
| May 31, 2024 | -28,925.00 |
| Feb 29, 2024 | 7,078.00 |
| Nov 30, 2023 | 41,196.00 |
| Aug 31, 2023 | 22,332.00 |
| May 31, 2023 | 31,800.00 |
| Feb 28, 2023 | 12,097.00 |
| Nov 30, 2022 | -17,915.00 |
| Aug 31, 2022 | -14,232.00 |
| May 31, 2022 | -2,509.00 |
| Feb 28, 2022 | 4,235.00 |
| Nov 30, 2021 | -21,214.00 |
| Aug 31, 2021 | 17,203.00 |